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Background: Preterm delivery increases the risk of neonatal morbidity and mortality. Studies suggest that maternal
diet may affect the prevalence of preterm delivery. The aim of this study was to assess whether maternal intakes of
seafood and marine long chain n-3 polyunsaturated fatty acids (LCn-3PUFA) from supplements were associated
with preterm delivery.
Methods: The study population included 67,007 women from the Norwegian Mother and Child Cohort Study.
Maternal food and supplement intakes were assessed by a validated self-reported food frequency questionnaire in
mid-pregnancy. Information about gestational duration was obtained from the Medical Birth Registry of Norway.
We used Cox regression to estimate hazard ratios (HR) with 95% confidence intervals (CI) for associations between
total seafood, lean fish, fatty fish, and LCn-3PUFA intakes and preterm delivery. Preterm was defined as any onset of
delivery before gestational week 37, and as spontaneous or iatrogenic deliveries and as preterm delivery at early,
moderate, and late preterm gestations.
Results: Lean fish constituted 56%, fatty fish 34% and shellfish 10% of seafood intake. Any intake of seafood above
no/rare intake (>5 g/d) was associated with lower prevalence of preterm delivery. Adjusted HRs were 0.76 (CI: 0.66,
0.88) for 1–2 servings/week (20–40 g/d), 0.72 (CI: 0.62, 0.83) for 2–3 servings/week (40–60 g/d), and 0.72 (CI: 0.61, 0.
85) for ≥3 servings/week (>60 g/d), p-trend <0.001. The association was seen for lean fish (p-trend: 0.005) but not
for fatty fish (p-trend: 0.411). The intake of supplementary LCn-3PUFA was associated only with lower prevalence of
early preterm delivery (before 32 gestational weeks), while increasing intake of LCn-3PUFA from food was
associated with lower prevalence of overall preterm delivery (p-trend: 0.002). Any seafood intake above no/
rare was associated with lower prevalence of both spontaneous and iatrogenic preterm delivery, and with
lower prevalence of late preterm delivery.
Conclusions: Any intake of seafood above no/rare consumption was associated with lower prevalence of
preterm delivery. The association was stronger for lean than for fatty fish. Intake of supplementary LCn-3PUFA
was associated only with early preterm delivery. The findings corroborate the current advice to include fish
and seafood as part of a balanced diet during pregnancy.
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Preterm delivery, which is defined as spontaneous or iat-
rogenic delivery before gestational week 37, is the major
cause of perinatal mortality and morbidity and is an im-
portant risk factor of long-term physical and mental dis-
abilities [1–4]. In Scandinavia and some other European
countries, the rate is around 5–7% of all deliveries, while
in the United States it is as high as 12% [5].
Preterm delivery accounts for a high financial burden
on healthcare and is a considerable trauma for those
involved [6–8]. Several factors have been shown to be
associated with preterm delivery, including maternal
demographic characteristics, reproductive history, infec-
tion, and biological and genetic markers [1, 9–11]. How-
ever, the aetiologies for preterm delivery are largely
unknown and currently there is no effective treatment to
reduce the rate of preterm delivery. Hence, it is import-
ant to identify potential modifiable factors in order to
prevent the complications and cost associated with pre-
term delivery.
Seafood is a rich source of essential nutrients including
protein, selenium, iodine, vitamin D, and the marine
long chain n-3 polyunsaturated fatty acids (LCn-3PUFA)
which have important structural and physiological roles
in the body, including neurological, immune, and cardio-
vascular systems [12–14].
In prospective observational studies, high levels of
maternal fish consumption during pregnancy have been
associated with longer gestation [15–17] and lower
prevalence of preterm delivery [16, 18], but the results
are not found in all studies [19–21]. The beneficial ef-
fects of fish consumption have primarily been attributed
to the LCn-3PUFA eicosapentaenoic acid (EPA) and
docosahexaenoic acid (DHA). Randomized controlled
trials have shown lower risk of preterm delivery, and
particularly early preterm delivery (<34 weeks) in
women supplemented with EPA and DHA during preg-
nancy [22–25].
The current dietary advice to pregnant women in
Norway and other countries is to include lean and fatty
fish as part of a balanced diet and to limit or avoid con-
sumption of contaminated species [26–28]. In Norway
there is a long tradition not only for eating seafood, but
also for use of cod liver oil. More studies of maternal
seafood and LCn-3PUFA intake in relation to preterm
delivery are needed to disentangle, if possible, the role of
different types of fish and supplementary LCn-3PUFA
[29, 30]. In the Norwegian Mother and Child Cohort
Study, women reported in detail their intakes of food
and dietary supplements during pregnancy, making it
possible to quantify their total seafood consumption and
subcategories of lean and fatty fish, as well as LCn-
3PUFA contributed by use of dietary supplements and
LCn-3PUFA contributed by food (i.e., fish) [31–34].The aim of the present study was to examine associa-
tions of maternal seafood and LCn-3PUFA supplement
intakes with the risk of preterm delivery. We hypothe-
sized that higher intake of seafood is associated with
lower risk of preterm delivery and that associations vary
by seafood categories. We investigated the associations
with all preterm deliveries and with the outcome strati-
fied as spontaneous and iatrogenic preterm delivery and
as early, moderate and late preterm delivery.
Methods
Population and study design
The Norwegian Mother and Child Cohort Study (MoBa)
is a prospective population-based pregnancy cohort
study conducted by the Norwegian Institute of Public
Health [35]. Participants were recruited from across
Norway from 1999 through 2008, and 40.6% of the in-
vited women participated. The cohort now includes
114,500 children, 95,200 mothers and 75,200 fathers.
Women were recruited to the study by postal invitation
before the routine free ultrasound examination around
gestational week 18. The women were asked to provide
blood and urine samples at baseline and to answer ques-
tionnaires at regular intervals during pregnancy and
after birth. Follow-up is conducted by questionnaires at
regular intervals and by linkage to national health regis-
tries [35, 36].
The data included in this study were from two
questionnaires answered around gestational weeks 17
(questionnaire 1) [37] and 22 (questionnaire 2) [38].
Questionnaire 1 was a general questionnaire covering
lifestyle, background, illness and health-related factors.
Questionnaire 2 was a semi-quantitative food frequency
questionnaire (FFQ), in which women reported their diet-
ary habits from the start of the pregnancy. The response
rates for the questionnaires during pregnancy were 95%
for questionnaire 1 and 92% for questionnaire 2 [39].
Pregnancy and birth records from the Medical Birth
Registry of Norway (MBRN) are linked to the MoBa
database [36].
The current study is based on version 5 of the
quality-assured data files released for research in 2010
(n = 108,264). To be included in the study, partici-
pants had to have delivered a live, singleton baby and
to have answered both the first general questionnaire
and the FFQ. They also had to have a valid energy in-
take between 4.5 and 20 MJ/day, resulting in n = 83,386
eligible for analysis. We excluded women with a duration
of pregnancy less than 22+0 or more than 41+6 weeks
(+days) (n = 6798), those with missing information about
parity (n = 51) and those with missing information about
previous preterm delivery (n = 42). To avoid the use of
multiple dependent observations in our analyses, women
who participated in the cohort more than once (n = 9488)
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a final study sample of 67,007 mother-infant pairs (Fig. 1).
Dietary assessment
The MoBa FFQ was completed around the 22nd week of
gestation, and the dietary data were collected from
February 2002 and onwards [32]. The MoBa FFQ is a
semi-quantitative questionnaire designed to capture diet-
ary habits during the first 4 to 5 months of pregnancy
[38]. The FFQ included questions about intake of 255 food
items with special emphasis on various seafood items.
There were 10 questions about cold cuts and spreads
made of fish or shellfish, 16 questions about fish or shell-
fish eaten for dinner, and four questions about cod liver
oil, cod liver oil capsules or fish oil capsules.
Nutrient calculations were performed with the use of
FoodCalc [40] and the Norwegian food composition
table [41]. In the FFQ, the women were asked to record
the use of dietary supplements. We have developed a
database for nutrient content in more than 1000 dietary
supplements reported by MoBa participants. For calcu-
lating intake of LCn-3PUFA from supplements we used
name and brand name combined with reported fre-
quency and amount. The FFQ has been thoroughly vali-
dated with regard to nutrients, foods and dietary
supplements [31, 33, 42].
Definition of fish and seafood variables and LCn-3PUFA
intake
The daily intakes (g/day) of fish items were grouped as
lean fish or fatty fish and included items eaten as breadFig. 1 Flow chart showing selection of the study participants from the Norspread, in salad, as dinner or as part of a mixed dish
such as fish fingers or fish au gratin. In composite fish
dishes, only the fish part of the dish was included in the
calculated fish intake. Lean fish species included cod,
saithe, haddock, pollock, halibut, plaice, flounder, tuna,
perch, pike, Atlantic cat fish and fish roe (0.3–6.0% fat).
Fatty fish species included mackerel, herring, salmon
and trout (10–24% fat). We also calculated the intakes of
shellfish (shrimp, crab and mussels (0.8–2.5% fat) and
fish liver. Total seafood was the combined intake of lean
fish, fatty fish, shellfish, and fish liver.
When evaluating the association between seafood con-
sumption and preterm delivery, seafood intake was
treated both as a continuous variable (g/d) and divided
into the following categories: 0–5 g/d, >5- ≤ 20 g/d,
>20- ≤ 40 g/ d, >40- ≤ 60 g/d, and ≥60 g/d. The same
categories were used in two previous studies that ex-
amined seafood intake in relation to infant size at
birth [34, 43]. Assuming a serving size of 140 g, these
categories correspond to; never/rare intake, <1 serv-
ing/week, 1to <2 servings/week, 2 to <3 servings/
week and 3 or more servings/week. When seafood
was eaten as bread spread, a serving size was esti-
mated to be 20–25 g. Lean and fatty fish variables
were examined as continuous variables and divided
into the five categories described above. In adjusted
analyses, these variables were mutually adjusted (i.e.,
both entered in the same models). Lean and fatty fish
intakes correlated with rs = 0.22 (p < 0.001), while cor-
relations for lean and fatty fish with shellfish and fish
liver were weaker.wegian Mother and Child Cohort Study
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sum of eicosapentaenoic acid (EPA) and docosahexae-
noic acid (DHA). The amount (mg/d) of LCn-3PUFA
contributed by dietary supplements (EPA and DHA in
cod liver oil, fish oil, cod liver oil capsules and fish oil
capsules) and the amount of LCn-3PUFA contributed by
fish (EPA and DHA) was estimated from the FFQ. The
variables for LCn-3PUFA (i.e., amount contributed from
food and amount contributed from supplements) were
examined as continuous and as ranked variables. LCn-
3PUFA from food and the total sum of LCn-3PUFA
from food and supplements were divided into quintiles.
In all models with seafood intake as the exposure, we
adjusted for the amount of LCn-3PUFA from supple-
ments divided into three categories with non-users as
one group and consumers ranked into two groups di-
vided by median.
Preterm delivery
We defined preterm delivery as delivery before gesta-
tional week 37+0 and used this as the primary outcome.
Gestational age in days was obtained from the MBRN
and determined by second-trimester ultrasound in 98.2%
of pregnancies and based on the last menstrual period in
the remaining cases [36]. Preterm delivery was cate-
gorised based on delivery initiation, i.e., spontaneous
preterm delivery (preterm labour or preterm prelabour
rupture of the membranes) or iatrogenic preterm deliv-
ery (induced or primary caesarean delivery on maternal
or foetal indications). Preterm delivery was also cate-
gorised into late (34+0 to 36+6 weeks), moderately (32+0
to 33+6 weeks) and early preterm (22+0 to 31+6 weeks).
Other variables
We included a range of potential covariates and exam-
ined their association with seafood intake and preterm
delivery. Information about maternal age at delivery and
previous preterm delivery was obtained from the MBRN.
We treated maternal age as a continuous variable. His-
tory of previous preterm delivery was analysed as a di-
chotomous variable (yes/no). Body mass index (BMI)
was calculated from prepregnancy weight and height
that women had reported in questionnaire 1. We only
included women with pre-pregnancy weight in the range
35–180 kg and height above 1.40 m. BMI was divided into
four categories (<18.5, 18.5–24.9, 25–29.9, ≥ 30 kg/m2)
and a missing category (n = 1723). Height was divided into
quartiles. Information about parity came from question-
naire 1 and from MBRN and was divided into two cat-
egories (nulliparous or parous). Information about marital
status, smoking in pregnancy, maternal education and
household income was obtained from questionnaire 1.
Marital status was divided into living alone or cohabiting
and smoking into yes (occasional or daily smoker) or no.Maternal education was divided into four categories:
≤12 years (high school or less), 13–16 years (3–4 years of
college/university), 17 + years (4 years or more of college/
university), or other/missing (n = 1418). Household in-
come was expressed as a combination of the participant’s
and her partner’s annual income and divided into three
categories: both partners <300,000 NOK, one partner
≥300,000 NOK, both partners ≥300,000 NOK, or missing
information (n = 1936). Information about alcohol intake
and whether or not the pregnancy was planned was di-
vided into yes or no. We used total energy intake (kJ) as a
continuous variable.Statistical methods
We used one-way analysis of variance for continuous
variables, chi-square test for categorical variables and
Mann-Whitney U test for nominal data to test differ-
ences between groups. The main exposure variables
were total seafood, including the subcategories lean and
fatty fish, and LCn-3PUFA from food and supplements.
We used Cox regression to estimate hazard ratios (HR)
for preterm delivery with 95% confidence intervals (CI).
Preterm delivery was the defined event and gestational
days the underlying time variable with day 153 as the
entry time (22 completed weeks of gestation). Follow-up
ended at the date of preterm delivery or at 259 days of
gestation (36 completed weeks of gestation), whichever
came first. In the separate analysis of spontaneous and
iatrogenic preterm delivery, the other category was cen-
sored but kept in the analysis. P for trend was obtained
by incorporating the categorical variables as linear terms
in the models. Variables included in the adjusted models
were: maternal age, education, history of previous pre-
term delivery, height, BMI, marital status, parity, smok-
ing, household income and total energy intake.
Repeating the analyses using logistic regression re-
sulted in odds ratios comparable to the hazard ratios ob-
tained by Cox regression. Hazard ratios and odds ratios
represent different association measures, but both ap-
proximate relative risks when the outcome is rare [44].
We examined the associations between seafood and
preterm delivery separately in women with prepregnant
BMI < 25 and those with prepregnant BMI ≥ 25 kg/m2,
and separately for nulliparous and parous pregnancies.
We also conducted other sensitivity analyses, including
complete case analysis.
We used visual inspection of the log-log plot to verify
that the proportional-hazard assumption was essentially
fulfilled All analyses were performed using PASW Statis-
tics software version 19 for Windows (SPSS Inc., IBM
Company, Chicago Ill., USA). All P values were two
sided and values below 0.05 were considered statistically
significant.
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Consumption of any seafood was reported by 97.7% of
all women in this study, 5.7% reported no lean fish, 13%
reported no fatty fish, 10.7% reported no shellfish and
91% reported no consumption of fish liver. The median
intakes of total seafood, lean fish and fatty fish were
33.4, 18.5 and 8.3 g/day, respectively. Lean and fatty fish
constituted on average 56 and 34% of the total seafood
intake (Table 1). The median total seafood intake corre-
sponds to 1–2 servings per week. The median amount
of LCn-3PUFA from total seafood was 0.25 g/d (mean
0.37 g/d), with median 0.039 g/d from lean fish (mean
0.044 g/d)) and 0.188 g/d from fatty fish (mean 0.298 g/
d). On average, fatty fish contributed 75% and lean fish
11% to the LCn-3PUFA intake from food (Table 1). Use
of LCn-3PUFA supplements was reported by 67% of the
women. The supplement users were divided into two
groups based on the median intake of supplemental
LCn-3PUFA (<0.30 g/d and ≥0.30 g/d). In the low group,
LCn-3PUFA intakes ranged from 0.01 g/d-0.29 g/d
(median 0.16 g/d) and in the high group from 0.30 g/d-
8.8 g/d (median 0.80 g/d).
Maternal characteristics differed across increasing cat-
egories of seafood intake and between LCn-3PUFA non-
supplement and supplement users (Table 2). Maternal
age and energy intake increased with increasing seafood
intake, while BMI decreased. Women in the lowest con-
sumption categories included more nulliparous women
and more women with low education and income than
to those in the higher consumption categories. Increas-
ing seafood intake was associated with not only increas-
ing intakes of fish and shellfish, but also by increasing
intakes of LCn-3PUFA from food and from supplements.
LCn-3PUFA supplement users had lower BMI, included
fewer first time mothers and fewer smokers, and in-
cluded more women with high education and income
than non-supplement users (Table 2).
The overall proportion of preterm delivery in the
study population was 5.4% (n = 3630), comprising
3.1% (n = 2051) spontaneous and 2.2% (n = 1419) iatro-
genic preterm deliveries, while information about deliveryTable 1 Calculated intake seafood and LCn-3PUFA from food and %
Norwegian Mother and Child Cohort Study 2002–2008
Median, g/d Mean, g/d % of total seafood
Total seafood 33.4 36.4
Lean fish 18.5 20.3 56
Fatty fish 8.3 12.2 34
Shellfish 2.4 3.6 10
Fish liver 0 0.3 0.7
Eggsa 7.8 11.4
Other food (poultry)a 18.8 22.4
aEggs and other food contain LCn-3PUFA (eicosapentaenoic and docosahexaenoicinitiation was missing for 88 preterm cases (0.1%). Of all
deliveries, 2659 (4.0%) were late preterm deliveries, 491
(0.7%) were moderately preterm and 480 (0.7%) were early
preterm deliveries (Table 3). In crude analyses using
continuous seafood intake variables, women with pre-
term deliveries had lower intakes of total seafood, lean
fish and fatty fish than women with term deliveries.
This was also found for LCn-3PUFA from food, while
there was no difference in the amount of LCn-3PUFA
from supplements between the groups. The differences
in seafood intakes were seen particularly for the subcat-
egories spontaneous and iatrogenic preterm delivery
and for late preterm delivery (Table 3).
Examining seafood intake by categories with the
never/rarely as the reference category, showed lower
prevalence of preterm delivery for all other intake cat-
egories (Table 4). For total seafood intake, the lowest risk
estimates were observed in the two highest intake cat-
egories with adjusted HR: 0.72 (95%CI: 0.62, 0.83) for 2-
≤ 3 servings per week and HR: 0.72 (95%CI: 0.61, 0.85)
for ≥3 servings per week, p-trend <0.001 (Table 3).
When lean and fatty fish were examined as separate var-
iables, significantly lower risk for preterm delivery was
observed for lean fish intake in all intake categories ex-
cept the highest category (p-trend: 0.005). For fatty fish,
lower risk was seen only for the intake category corre-
sponding to 1- ≤ 2 servings per week (p-trend 0.411).
LCn-3PUFA from supplements was not associated with
overall preterm delivery (Fig. 2 and Table 4).
We further examined whether the associations be-
tween LCn-3PUFA from supplements and preterm deliv-
ery differed between groups of women with low and
high seafood intake. Low seafood intake was defined as
no seafood intake and intakes below the 5th percentile.
Total seafood intake was also ranked into tertiles,
quintiles and deciles, and the association between
LCn-3PUFA from supplements and preterm delivery
examined in each strata separately. No significant as-
sociation between LCn-3PUFA from supplements and
preterm delivery was observed at any level of seafood
intake (results not shown). Furthermore, we examinedcontribution from subcategories in n = 67,007 women in the
LCn-3PUFA, median g/d LCn-3PUFA, mean g/d % of LCn-3PUFA
0.248 0.365 92
0.039 0.044 11
0.188 0.298 75
0 0.009 2.2
0 0.014 3.7
0.014 0.019 4.8
0.010 0.012 3.0
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Table 3 Maternal intake (g/day) of seafood and marine long chain n-3 polyunsaturated fatty acids (LCn-3PUFA) from food
and dietary supplements in 67,007 women with and without preterm delivery (PTD) in the Norwegian Mother and Child Cohort Study
(MoBa) 2002–2008
N (%) Total seafood Lean fish Fatty fish Food LCn-3PUFA Suppl. LCn-3PUFA
Median (P5, P95) Median (P5, P95) Median (P5, P95) Median (P5, P95) Median (P5, P95)
Overall preterm delivery
No 63,377 (94.6) 33.5 (6.2, 75.9) 18.5 (0, 45.2) 8.3 (0, 38.3) 0.35 (0.10, 1.27) 0.16 (0, 1.60)
Yes 3630 (5.4) 32.1 (3.5, 78.6) 17.7 (0, 44.8) 7.6 (0, 40.3) 0.34 (0.08, 1.32) 0.16 (0, 1.60)
Crude p-valuea <0.001 <0.001 <0.001 <0.001 0.936
Adjusted p-valueb 0.004 0.008 0.349 0.171 0.879
Subcategories by delivery initiationc
Spontaneous preterm deliveries
No 63,377 (94.6) 33.5 (6.2, 75.9) 18.5 (0, 45.2) 8.3 (0, 38.3) 0.35 (0.10, 1.27) 0.16 (0, 1.60)
Yes 2051 (3.1) 31.7 (3.0, 78.4) 17.9 (0, 45.1) 7.6 (0, 39.3) 0.33 (0.08, 1.32) 0.16 (0, 1.60)
Crude p-value <0.001 0.011 0.001 <0.001 0.680
Iatrogenic preterm delivery
No 63,377 (94.6) 33.5 (6.2, 75.9) 18.5 (0, 45.2) 8.3 (0, 38.3) 0.35 (0.10, 1.27) 0.16 (0, 1.60)
Yes 1491 (2.2) 33.0 (4.1, 78.6) 17.5 (0, 45.3) 7.6 (0, 42.6) 0.35 (0.09, 1.33) 0.15 (0, 1.60)
Crude p-value 0.031 0.008 0.045 0.123 0.294
Subcategories by week of delivery
Late PTD (35 to <37 w)
No 63,377 (94.6) 33.5 (6.2, 75.9) 18.5 (0, 45.2) 8.3 (0, 38.3) 0.35 (0.10, 1.27) 0.16 (0, 1.60)
Yes 2659 (4.0) 31.8 (3.5, 78.3) 17.7 (0, 44.1) 7.6 (0, 39.6) 0.34 (0.09, 1.32) 0.16 (0, 1.60)
Crude p-value <0.001 <0.001 0.002 0.001 0.720
Moderately PTD (32 to <34w)
No 63,377 (94.6) 33.5 (6.2, 75.9) 18.5 (0, 45.2) 8.3 (0, 38.3) 0.35 (0.10, 1.27) 0.16 (0, 1.60)
Yes 491 (0.7) 33.6 (3.0, 81.0) 17.5 (0, 45.5) 8.1 (0, 44.1) 0.35 (0.08, 1.44) 0.15 (0, 1.60)
Crude p-value 0.530 0.155 0.378 0.712 0.386
Early PTD (22 to <32 w)
No 63,377 (94.6) 33.5 (6.2, 75.9) 18.5 (0, 45.2) 8.3 (0, 38.3) 0.35 (0.10, 1.27) 0.16 (0, 1.60)
Yes 480 (0.7) 32.0 (3.3, 78.0) 18.1 (0, 45.8) 7.2 (0, 38.6) 0.33 (0.09, 1.23) 0.14 (0, 1.60)
Crude p-value 0.102 0.467 0.018 0.016 0.050
P5: 5th percentile, P95: 95th percentile
aCrude P-values from non-parametric Mann-Whitney U test
bAdjusted P-values from Cox regression with continuous seafood variables adjusted for the other seafood and LCn-3PUFA variables when relevant, maternal age,
pre-pregnancy BMI, height, parity, energy intake, maternal education, smoking, marital status, household income and previous preterm delivery
cMissing data on delivery initiation for 88 preterm deliveries
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able and ranked into quintiles and deciles. No signifi-
cant associations with preterm delivery were indicated
(results not shown).
We repeated the analysis using the calculated LCn-
3PUFA intake from food as the exposure and the
lowest quintile as reference category. Lower risk esti-
mates were seen in all the other quintiles (Additional
file 1: Table S1), with the lowest HR observed in
quintile 4 (HR 0.83, CI: 0.75, 0.92), p-trend 0.002.
However, when we summed the intake of LCn-3PUFA
from food and supplements, the association with pre-
term delivery was significant only in the third quintile(Additional file 1: Table S1). When LCn-3PUFA from
food was included in a model with seafood as the expos-
ure, the hazard ratios for seafood and preterm delivery
remained significant, but with wider confidence intervals
(i.e., for 2–3 servings/week HR: 0.77 (95%CI: 0.64, 0.92)
and for ≥3 servings/week HR: 0.75 (95%CI: 0.62, 0.92).
We further analysed associations between seafood in-
take and subcategories of preterm delivery. Any intake
of seafood beyond no/rare intake was associated with
lower prevalence of both spontaneous and iatrogenic
preterm deliveries (Table 5), with HRs similar to those
seen for any preterm (20–30% risk reduction). In these
analyses, lean fish had a stronger influence on the
Table 4 Associations between total seafood intake, lean and fatty fish intake and marine long chain n-3 polyunsaturated fatty acids
(LCn-3PUFA) from supplements and preterm delivery (PTD). N = 67,007 women in the Norwegian Mother and Child Cohort Study
(MoBa) 2002–2008
All PTD Unadjusted Adjusted
n n (%) HRa (95% CI) HRab (95% CI)
Total seafood
≤ 5 g/d (never/rarely) 2966 220 (7.4) 1 1
> 5–20 g/d (<1 serving/week) 12,299 713 (5.8) 0.77 (0.66, 0.90) 0.80 (0.69, 0.93)
> 20–40 g/d (1–2 servings/week) 27,045 1440 (5.3) 0.71 (0.62, 0.82) 0.76 (0.66, 0.88)
> 40–60 g/d (2–3 servings/week) 16,432 824 (5.0) 0.67 (0.57, 0.77) 0.72 (0.62, 0.83)
> 60 g/d (≥3 servings/week) 8265 433 (5.2) 0.70 (0.59, 0.82) 0.72 (0.61, 0.85)
P for trendc <0.001 <0.001
Lean fish
≤ 5 g/d (never/rarely) 7453 492 (6.6) 1 1
> 5–20 g/d (<1 serving/week) 29,159 1578 (5.4) 0.82 (0.74, 0.90) 0.88 (0.79, 0.98)
> 20–40 g/d (1–2 servings/week) 24,834 1277 (5.1) 0.77 (0.70, 0.86) 0.86 (0.77, 0.95)
> 40–60 g/d (2–3 servings/week) 4799 236 (4.9) 0.74 (0.63, 0.86) 0.78 (0.67, 0.92)
> 60 g/d (≥3 servings/week) 762 47 (6.2) 0.93 (0.69, 1.26) 0.91 (0.67, 1.23)
P for trendc <0.001 0.005
Fatty fish
≤ 5 g/d (never/rarely) 22,035 1305 (5.9) 1 1
> 5–20 g/d (<1 serving/week) 33,297 1693 (5.1) 0.85 (0.80, 0.92) 0.91 (0.85, 0.98)
> 20–40 g/d (1–2 servings/week) 8654 448 (5.2) 0.87 (0.78, 0.97) 0.91 (0.81, 1.02)
> 40–60 g/d (2–3 servings/week) 1898 116 (6.1) 1.03 (0.85, 1.25) 1.06 (0.87, 1.28)
> 60 g/d (≥3 servings/week) 1123 68 (6.1) 1.03 (0.80, 1.31) 1.02 (0.80, 1.31)
P for trendc 0.088 0.411
LCn-3PUFA from supplements
No supplement 22,018 1093 (5.4) 1 1
< 0.30 g/d (median 0.16 g/d) 22,493 1207 (5.4) 0.99 (0.92, 1.07) 1.00 (0.92, 1.09)
≥ 0.30 g/d (median 0.80 g/d) 22,496 1230 (5.5) 1.01 (0.93, 1.09) 1.02 (0.94, 1.11)
P for trendc 0.818 0.567
aHR: Hazard Ratio (Cox regression)
bAdjusted for the other seafood categories and LCn-3PUFA from supplements, maternal age, pre-pregnancy BMI, height, parity, energy intake, maternal education,
smoking, marital status, household income and previous preterm delivery
cP for linear trend obtained by incorporating variable as linear term
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delivery (p-trend: 0.012 for iatrogenic vs 0.219 for spon-
taneous), while fatty fish and LCn-3PUFA from supple-
ments did not show a significant trend with either
spontaneous or iatrogenic preterm delivery.
When preterm delivery was examined separately ac-
cording to late, moderate or early onset, any increase in
seafood beyond no/rare intake was associated with lower
risk in the late preterm group, with HRs resulting in 20–
30% risk reduction (p-trend <0.001) (Table 6). Although
not statistically significant, the risk estimates for moder-
ately and early preterm delivery were comparable to
those for late preterm delivery. In these analyses LCn-
3PUFA from supplements was not associated with lateor moderately preterm delivery, while a non-significant
trend was indicated for early preterm delivery, HR 0.84
(CI: 0.67, 1.05) and HR 0.81 (CI: 0.65, 1.01) for the two
supplement intake groups versus no LCn-3PUFA from
supplements (p-trend 0.072) (Table 6).
Statistical significance of the adjusted associations was
similar whether the seafood and LCn-3PUFA variables
were modelled as continuous or categorical variables.
Obesity is a risk factor of preterm delivery, and we ex-
amined the associations between seafood intake and pre-
term delivery separately in women with pre-pregnant
BMI <25 (n = 45,119) and those with BMI ≥ 25 kg/m2
(n = 20,165). The prevalence of preterm delivery was
5.0% in the group with BMI <25 and 6.3% in the
Fig. 2 Associations (hazard ratio (HR) and 95% confidence intervals (CI)) between intakes of lean fish, fatty fish and marine long chain n-3 polyun-
saturated fatty acids (LCn-3PUFA) from supplements and preterm delivery. Intakes are mutually adjusted and adjusted for maternal age, pre-pregnancy
BMI, height, parity, energy intake, maternal education, smoking, marital status, household income and previous preterm delivery. N = 67,007 women in
the Norwegian Mother and Child Cohort Study (MoBa) 2002–2008
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ery with seafood intake above 1 serving a week (20-30%
risk reduction) was seen in both strata, although slightly
stronger HRs were observed in women with BMI <25 than
in those with BMI ≥25 kg/m2 (Additional file 2: Table S2).
In our study sample, preterm delivery was more preva-
lent in nulliparous (6.3%) than in parous women (4.3%),
and we also examined the associations between seafood
intake and preterm delivery separately in nulliparous
(n = 34,731) and parous women (n = 32,276). Lower
HRs for preterm delivery were seen in both strata,
but the effect size was smaller and the confidence in-
tervals wider in parous than in nulliparous women
(Additional file 2: Table S2). LCn-3PUFA from dietary
supplements was not associated with preterm delivery
in any of these analyses (Additional file 2: Table S2
and Additional file 3: Table S3).
Finally we tested whether the associations between
seafood intake and preterm delivery were consistent in
subcategories of maternal age, education and smoking.
The risk estimates were comparable in all sub-strata, but
in small groups e.g., smokers, the confidence intervals
were wider (results not shown).
Excluding women who had a registered diagnosis of
diabetes in the MBRN (n = 1007) or adjusting for dia-
betes as an independent variable did not change theassociations between seafood and LCn-3PUFA and pre-
term delivery (results not shown).
Discussion
The main finding in the present study was the significant
association between maternal total seafood intake and
lower likelihood of preterm delivery. The association
was mainly explained by intake of lean fish. The results
for the calculated intake of LCn-3PUFA from food
reflected the results for seafood intake, while LCn-
3PUFA from supplements was not associated with the
outcome, with the exception of a borderline significant
trend for early preterm delivery. Lower prevalence of
preterm delivery with increasing seafood intake was ob-
served for both the subcategories spontaneous and iatro-
genic preterm delivery. Significantly lower HR was
observed for moderately increased intakes relative to no/
low intake, while we observed no additional risk reduc-
tion for the highest intake categories.
A beneficial relationship between seafood consump-
tion and preterm delivery has been reported in several
studies [15–18, 45]. In a previous study in nulliparous
women in MoBa focusing on the Mediterranean diet, we
found that eating fish at least twice weekly during preg-
nancy was associated with lower risk of preterm delivery
[46]. We defined Mediterranean diet according to five
Table 5 Associations between seafood intake and marine long chain n-3 polyunsaturated fatty acids (LCn-3PUFA) from supplements
and the subcategories spontaneous and iatrogenic preterm delivery. N = 66,919a women in the Norwegian Mother and Child Cohort
Study (MoBa) 2002–2008
All Spontaneous Adjusted Iatrogenic Adjusted
n PTD n (%) HRab (95% CI) PTD n (%) HRbc (95% CI)
2051 (3.1) 1491 (2.2)
Total seafood
≤ 5 g/d (never/rarely) 2961 129 (4.4) 1 86 (2.9) 1
> 5–20 g/d (<1 serving/week) 12,275 405 (3.3) 0.79 (0.64, 0.96) 284 (2.3) 0.81 (0.63, 1.03)
> 20–40 g/d (1–2 servings/week) 27,010 802 (3.0) 0.73 (0.61, 0.89) 603 (2.2) 0.79 (0.63, 0.99)
> 40–60 g/d (2–3 servings/week) 16,416 469 (2.9) 0.71 (0.58, 0.86) 339 (2.1) 0.74 (0.58, 0.94)
> 60 g/d (≥3 servings/week) 8257 246 (3.0) 0.73 (0.58, 0.90) 179 (2.2) 0.71 (0.55, 0.92)
P for trendd 0.009 0.013
Lean fish
≤ 5 g/d (never/rarely) 7437 278 (3.7) 1 198 (2.7) 1
> 5–20 g/d (<1 serving/week) 29,118 884 (3.0) 0.88 (0.77, 1.02) 653 (2.2) 0.89 (0.76, 1.05)
> 20–40 g/d (1–2 servings/week) 24,806 723 (2.9) 0.88 (0.76, 1.02) 526 (2.1) 0.84 (0.71, 0.99)
> 40–60 g/d (2–3 servings/week) 4797 139 (2.9) 0.85 (0.69, 1.04) 95 (2.0) 0.74 (0.57, 0.95)
> 60 g/d (≥3 servings/week) 761 27 (3.5) 0.99 (0.67, 1.47) 19 (2.5) 0.81 (0.50, 1.31)
P for trendc 0.219 0.012
Fatty fish
≤ 5 g/d (never/rarely) 22,003 746 (3.4) 1 527 (2.4) 1
> 5–20 g/d (<1 serving/week) 33,257 949 (2.9) 0.89 (0.81, 0.99) 704 (2.1) 0.94 (0.84, 1.06)
> 20–40 g/d (1–2 servings/week) 8640 256 (3.0) 0.91 (0.79, 1.06) 178 (2.1) 0.89 (0.75, 1.06)
> 40–60 g/d (2–3 servings/week) 1897 59 (3.1) 0.94 (0.71, 1.23) 56 (3.0) 1.26 (0.95, 1.66)
> 60 g/d (≥3 servings/week) 1122 41 (3.7) 1.10 (0.80, 1.51) 26 (2.3) 0.94 (0.63, 1.39)
P for trendc 0.411 0.804
LCn-3PUFA from supplements
No supplement 21,999 671 (3.1) 1 503 (2.3) 1
< 0.30 g/d (median 0.16 g/d) 22,456 671 (3.0) 0.97 (0.87, 1.09) 499 (2.2) 1.03 (0.90, 1.17)
≥ 0.30 g/d (median 0.80 g/d) 22,464 709 (3.2) 1.03 (0.92, 1.15) 489 (2.2) 1.01 (0.89, 1.15)
P for trendd 0.626 0.872
aMissing data on delivery initiation for 88 preterm deliveries
bHR: Hazard Ratio (Cox regression)
cAdjusted for the other seafood categories and LCn-3PUFA from supplements, maternal age, pre-pregnancy BMI, height, parity, total energy intake, maternal edu-
cation, smoking, marital status, household income and previous preterm delivery
dP for linear trend obtained by incorporating variable as linear term
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delivery were examined for adherence to each criter-
ion and for all criteria combined. Only the criterion
‘eating fish at least twice weekly’ was significantly as-
sociated with the outcome (adjusted OR: 0.84; 95%
CI: 0.74, 0.95) [46]. A more recent study from MoBa
examining maternal dietary patterns showed a re-
duced risk of preterm delivery associated with high
adherence to a traditional dietary pattern charac-
terised by i.e., potatoes, fish dishes and lean fish [47].
The present study complements the previous studies
by including more detailed quantification of seafood
intakes, by separating between lean and fatty fishintakes, and by examining LCn-3PUFA from food and
supplements as independent exposure variables.
Associations between fish consumption and LCn-
3PUFA with increased length of gestation observed in
previous studies have been explained by the anti-
inflammatory properties of these fatty acids modulating
the inflammatory pathways leading to cervical ripening
and initiation of labour and delivery [48–51]. Klebanoff
et al. (2011) studied fish consumption, erythrocyte fatty
acids, and preterm delivery in a high-risk population of
women with a prior preterm delivery. The women par-
ticipated in a randomized controlled trial of n-3 supple-
mentation [52]. Women were randomized to receive
Table 6 Associations between total seafood intake and the subcategories late preterm delivery (35 to <37 w), moderately preterm
delivery (32 to <34 w) and early preterm delivery (22 to <32 w). N = 67,007 mothers in the Norwegian Mother and Child Cohort
Study (MoBa) 2002–2008
All PTD Unadjusted Adjusted
n (%) HRa (95% CI) HRb (95% CI)
Late PTD (35 to <37 w) 2659 (4.0)
Total seafood intake
≤ 5 g/d (never/rarely) 2903 157 (5.4) 1 1
> 5–20 g/d (<1 serving/week) 12,111 525 (4.3) 0.80 (0.67, 0.95) 0.82 (0.68, 0.98)
> 20–40 g/d (1–2 servings/week) 26,684 1079 (4.0) 0.74 (0.63, 0.88) 0.78 (0.66, 0.92)
> 40–60 g/d (2–3 servings/week) 16,194 586 (3.6) 0.66 (0.55, 0.79) 0.69 (0.58, 0.83)
> 60 g/d (≥3 servings/week) 8144 312 (3.8) 0.70 (0.58, 0.85) 0.71 (0.58, 0.86)
P for trendc <0.001 <0.001
LCn-3PUFA from supplements
No supplement 21,676 851 (3.9) 1 1
< 0.30 g/d (median 0.16 g/d) 22,203 917 (4.1) 1.05 (0.96, 1.16) 1.07 (0.97, 1.18)
≥ 0.30 g/d (median 0.80 g/d) 22,157 891 (4.0) 1.03 (0.93, 1.13) 1.04 (0.94, 1.15)
P for trendc 0.609 0.450
Moderately PTD (32 to <34w) 491 (0.7)
Total seafood intake
≤ 5 g/d (never/rarely) 2778 32 (1.2) 1 1
> 5–20 g/d (<1 serving/week) 11,680 94 (0.8) 0.70 (0.47, 1.04) 0.75 (0.50, 1.12)
> 20–40 g/d (1–2 servings/week) 25,784 179 (0.7) 0.60 (0.41, 0.88) 0.68 (0.47, 0.99)
> 40–60 g/d (2–3 servings/week) 15,730 122 (0.8) 0.67 (0.46, 0.99) 0.77 (0.52, 1.15)
> 60 g/d (≥3 servings/week) 7896 64 (0.8) 0.70 (0.46, 1.07) 0.78 (0.51, 1.20)
P for trendc 0.432 0.792
LCn-3PUFA from supplements
No supplement 20,987 169 (0.8) 1 1
< 0.30 g/d (median 0.16 g/d) 21,424 138 (0.6) 0.83 (0.66, 1.05) 0.84 (0.66, 1.06)
≥ 0.30 g/d (median 0.80 g/d) 21,457 191 (0.9) 1.15 (0.94, 1.42) 1.19 (0.95, 1.48)
P for trendc 0.158 0.093
Early PTD (22 to <32 w) 480 (0.7)
Total seafood intake
≤ 5 g/d (never/rarely) 2777 31 (1.1) 1 1
> 5–20 g/d (<1 serving/week) 11,680 94 (0.8) 0.72 (0.48, 1.08) 0.77 (0.51, 1.16)
> 20–40 g/d (1–2 servings/week) 25,787 182 (0.7) 0.63 (0.43, 0.92) 0.71 (0.48, 1.04)
> 40–60 g/d (2–3 servings/week) 15,724 116 (0.7) 0.66 (0.44, 0.98) 0.75 (0.50, 1.12)
> 60 g/d (≥3 servings/week) 7899 57 (0.7) 0.65 (0.42, 0.99) 0.68 (0.43, 1.06)
P for trendc 0.116 0.196
LCn-3PUFA from supplements
No supplement 21,005 180 (0.9) 1 1
< 0.30 g/d (median 0.16 g/d) 21,438 152 (0.7) 0.83 (0.67, 1.03) 0.84 (0.67, 1.05)
≥ 0.30 g/d (median 0.80 g/d) 21,414 148 (0.7) 0.81 (0.65, 1.00) 0.81 (0.65, 1.01)
P for trendc 0.049 0.072
aHR: Hazard Ratio (Cox regression)
bAdjusted for maternal age, pre-pregnancy BMI, height, parity, energy intake, maternal education, smoking, marital status, household income, previous preterm
delivery and LCn-3PUFA from supplements
cP for linear trend obtained by incorporating variable as linear term
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mid-gestation (weeks 16–21). The results showed that
women who reported the lowest fish consumption at
gestational weeks 16–21 had higher risk of recurrent
preterm birth than those who ate fish more frequently.
The lowest occurrence of preterm birth was seen among
women who ate fish approximately 2–3 times/week,
while more frequent fish consumption was not associ-
ated with further risk reduction [52]. Interestingly, the
lowest occurrence of preterm birth was observed among
women in the second quartile of erythrocyte LCn-
3PUFA concentrations, and no benefit of LCn-3PUFA
supplementation was found, regardless of baseline fish
consumption and erythrocyte n-3 concentration [52]. A
multicentre randomized control trial in seven European
countries comprising women with previous pregnancy
complications found that fish oil supplementation (2.7 g
LCn-3PUFA daily) delayed the onset of delivery for
women with low (mean 16 g/d) and medium fish intake
(mean 23 g/day), but not for women with high fish in-
take (mean 36 g/day) at baseline [53], suggesting that
the effect of fish oil supplementation on timing of deliv-
ery depends on a woman’s fish intake. In the current
study, however, no association between LCn-3PUFA
from supplements and overall preterm delivery was evi-
dent at any level of seafood intake. However, our finding
of borderline significantly lower risk of early preterm de-
livery (<32 weeks) in women using LCn-3PUFA is in line
with results from experimental studies in the US and
Australia which found that supplementation with 0.6–
0.8 g/d DHA reduced the prevalence of early preterm
births in low risk pregnancies [22, 23]. Contrary to our
findings, a prospective study in pregnant women in Mas-
sachusetts found no associations between intake of fish
or LCn-3PUFA from food and preterm delivery [20].
Furthermore, another recent study from the US reported
an increased risk of preterm in women with high intakes
of lean fish [21].
In the present study, LCn-3PUFA from fish paralleled
the results obtained for seafood, while LCn-3PUFA from
supplements was not associated with overall preterm de-
livery. The association between seafood intake and pre-
term delivery remained significant also when adjusted
for LCn-3PUFA from food, indicating that the observed
associations between seafood consumption and lower
prevalence of preterm delivery cannot be explained only
by LCn-3PUFA. Alternative explanations could be other
components in fish (e.g., proteins, iodine, and selenium)
or other aspects of fish consumption (e.g., foods typically
eaten with fish or foods displaced by fish) might modulate
the inflammatory pathways leading to delivery. The effects
of fatty fish, lean fish and LCn-3PUFA intake on inflam-
mation have been studied in some intervention studies
[54, 55]. In one study, participants were randomlyallocated to receive dietary advice plus either 300 g of
fatty fish (salmon) or 300 g of lean fish (cod) per week
for 6 months, or only dietary advice. Interestingly, the
effect estimates did not differ between the lean and
fatty fish groups, and a significantly lower concentra-
tion of the systemic inflammation marker C-reactive
protein was found in both fish groups compared to the
control group [54]. Another study investigated the ef-
fects of weight loss and seafood consumption in three
intervention groups (salmon, cod, or LCn-3PUFA sup-
plementation) and controls on inflammation parame-
ters during energy restriction. The largest decrease in
inflammation parameters was observed for salmon con-
sumption, and no decrease was seen for LCn-3PUFA
supplementation [55]. It could also be speculated that
fish consumption may influence the gut microbiota
which is crucial for optimal functioning of the digestive
and immune systems [56]. Two experimental studies
explored whether fish consumption influenced gut
microbiota composition and local markers of gut in-
flammation without convincing results [54, 57]. How-
ever, in one of these studies a significant effect on the
systemic inflammatory markers was observed for both
lean and fatty fish [54].
An issue of particular concern when it comes to sea-
food consumption in women of childbearing age, is the
concomitant exposure to environmental pollutants, e.g.,
methylmercury, polychlorinated biphenyls and perfluori-
nated alkylated substances, which may counteract the
beneficial effects of fish consumption [28, 58–61]. How-
ever, a systematic review of environmental contaminant
exposures and preterm birth found no consistent evi-
dence for chemical exposure and increased risk of pre-
term delivery [62]. Likewise, studies in MoBa examining
associations between maternal exposure to environmen-
tal pollutants primarily contributed by seafood and preg-
nancy outcomes showed no increased risk of preterm
delivery [63, 64]. The result of the present study corrob-
orates the current advice to pregnant women to include
fish and seafood as part of a balanced diet and restricting
the intake of species and items with known high concen-
trations of environmental pollutants [26, 65].
The strengths of this study include the prospective
design and detailed information about maternal diet,
demography, socioeconomic factors, and pregnancy
outcomes. Thanks to the large sample size we were
able to examine the associations between seafood in-
take and preterm delivery in subcategories. Partici-
pants in MoBa were recruited from urban and rural,
coastal and inland regions and represented different
socioeconomic groups. Dietary intake was assessed
using an FFQ that was specifically developed and vali-
dated for use in this cohort [31, 32]. The FFQ in-
cluded questions with special emphasis on various
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the reported intakes of lean and fatty fish and LCn-
3PUFA supplements were reflected by blood and
urine samples [33]. The food frequency method chal-
lenges respondents with rather complex cognitive
tasks and are more suitable for ranking participants
according to high and low intakes than for precise in-
take calculations. Therefore, differential misclassifica-
tion of seafood and n-3 supplement intakes cannot be
excluded, but is as likely to occur in women with
term delivery as in women with preterm delivery.
The somewhat low response rate in MoBa is a concern
and participants are not representative of all pregnant
women in Norway. The potential bias due to self-
selection has been evaluated by comparison of eight
exposure-outcome associations reported both in MoBa
and in the MBRN. Significant differences in prevalence
estimates were found for most variables, e.g., MoBa
participants included less smokers than the general
pregnant population. In spite of this, there were no
statistically relative differences in association mea-
sures, e.g., prenatal smoking and low birthweight [66].
It is a strength that the women who do participate
remain in the study, illustrated by a response rate of
more than 90% for the three extensive questionnaires an-
swered during pregnancy [39]. However, the study is ob-
servational and we cannot rule out the possibility that
residual or unmeasured confounding may still exist.
Conclusions
This study showed that maternal seafood consumption
was associated with reduced risk of preterm delivery.
The association was mainly explained by intake of lean
fish. The association was seen for subcategories spontan-
eous, iatrogenic and late preterm delivery. Intake of
LCn-3PUFA from seafood was associated with preterm
delivery, while intake of LCn-3PUFA from supplements
was associated only with early preterm delivery. The as-
sociation between supplementary LCn-3PUFA and pre-
term delivery did not differ between women with low or
high seafood intake. Furthermore, the association be-
tween seafood intake and reduced risk of preterm deliv-
ery remained significant when adjusted for LCn-3PUFA
from food, indicating that the observed associations can-
not be explained only by LCn-3PUFA and that other
properties related to fish and seafood consumption may
also be of importance. The findings corroborate the
current advice to include fish and seafood as part of a
balanced diet during pregnancy. Preterm delivery is a
serious public health problem resulting in high societal
costs, and no effective preventive strategies for the gen-
eral population exist. Dietary changes have low cost and
low risk compared with medical interventions and even
moderate changes may be of public health importance.Additional files
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